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ABSTRACT, Intensive use of the organophosphate insecticide malathion against adults and temephos against
larvae of Aedes aegypti in Mexico over the past 30 years has led to problems requiring the use of new larvicides-
Toward this objeciive, Bacillus thuringiensis var. israelensis (Bti), a taryet-specific and environmentally safer
control agent, was evaluated. Laboratory bioassays were done to determine the susceptibility of 2nd- and 3rd-
stage larvae of Ae. aegypti to Vectobac@ 12 AS (aqueous suspension,6O0 ITU/mg). A median lethal concentra-
tion of 0.0104 ppm and a 957o lethal concentfation of 0- 18 ppm were determined after 24 h of exposure to the
agent. The values obtained were adjusted for field application and were further tested in the field by the State
oT Nu"uo Le6n, Mexico Vector Control Program. Suspensions of Bti were poured into pipe-water trucks and
transferred to domestic 2o}-gal metal water drums. Larval populations were reduced during a 2-week study
period. However, residents complained about a fine dusty film on the water surface. Nevertheless, these results
are promising for future Bti field applications.
KEY WORDS Dengue, insecticide resistance, mosquito control, Bacillus thuringiensis vat. israelensis, Yec-
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INTRODUCTION
Classical dengue, along with its more serious
forms dengue hemorrhagic fever and dengue shock
syndrome, is a serious health problem in many
parts of the Americas, and may affect national
economies in the region (PAHO 1994). Dengue re-
appeared in Mexico during the late 1970s, and
since then, yearly outbreaks have occurred consis-
tently throughout temperate and tropical areas (Go-
mez-Dantes 1992). Dramatically, the northeastern
region covering the states Tamaulipas, Nuevo Le6n,
and Coahuila reported nearly TOVo of the 14,000
confirmed cases registered nationwide (Secretaria
de Salud, Mexico 1999). The increasing trend of
dengue outbreaks is blamed on several factors. No-
tably, traditional, centralized, and vertically struc-
tured programs are largely ineffective, principally
because they are neither affordable nor manage-
able. In addition, the explosive growth of urban ar-
eas, limited government resources, and inadequate
field personnel account for the epidemic dispersal
in Latin America (Gubler and Kuno 1997). On the
other hand, the excessive reliance on and improper
application of insecticides, plus reports of insecti-
cide resistance, have all brought attention to the
need for alternative control methods. Insecticides
have exerted a selection pressure that has favored
the survival of strains with increased resistance. In
Mexico, as in most countries, many different insec-
ticides have been used for vector control. In the
1950s, DDT was used for malaria control. Since
then, organophosphate insecticides such as mala-
thion (adulticide) and temephos (larvicide), have
been employed intensively. Malathion was used as
a space spray or applied by ultra-low volume cold
fogging, whereas temephos granules were applied
to water containing domestic and peridomestic in-
festations of Aedes aegypti (L.). In Monterrey City,
both 200-liter metal drums and discarded tires have
become the most important breeding sites for Ae.
aegypti larvae. Therefore, since 1981, larval control
has been conducted intensely annually witlr lVo te'
mephos granules. Presently, strong indications exist
that resistance to this organophosphate is occurring,
and temephos resistance has been confirmed else-
where in the Caribbean area. Wirth and Georghiou
(1999) reported resistance in the Virgin Islands,
where temephos has been used intensively in the
Ae. aegypti Dengue Control Program.
Development of resistance to Bacillus thurin-
giensis var. israelensis (Bti) by mosquitoes has been
much less pronounced (Georghiou and Wirth
1977), and this insecticide has proven to be highly
efficient for the control of many mosquito species
and is relatively nondisruptive to aquatic environ-
ments. After a dengue outbreak in 1999, the Nuevo
Le6n State Ae. aegypti Control Program requested
tests on the use of Vectobac@ 12 AS, the Bti product
available in the Mexican market. The aims of the
study were the determination of Ae. aegypti srts-
ceptibility to B/i under laboratory conditions and
the establishment of field application rates for local
mosquito breeding sites.
MATERIALS AND METHODS
Aedes aegypti susceptibill4y.' Vectobac 12 AS
(aqueous suspension, 600 ITU/mg) of Bti (H-14)
manufactured by Abbott Laboratories, North Chi-
cago, IL, USA, was used to determine mortality-
concentration lines. The bioassays utilized 2nd- and
3rd-stage larval Ae. aegypti. Laboratory ambient
conditions were TOVo relative humidity and 28-
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Table. 1 Description of Bacillus thuringiensis var. israelensis (Bti) concentrations in bioassavs to establish
mortality-{oncentration line of VectoBac 12 AS@ on 2nd- and 3rd-stage larvae of Aedes aegypti in
Monterrey, Mexico.
Bioassay Bti concentrations (ppm) Number of exposed larvae
1
2
3
4
6
7
8
9
0, 0.0002, 0.0004, 0.0008, 0.015, 0.030, 0.06
0, 0.0015, 0.0030, 0.0060. 0.0090. o.o12. o.02
0, 0.006, 0.009, 0.012, 0.020, 0.025, 0.030, 0.035, 0.040
0, 0.006, 0.009, 0.012, 0.020,0.025.0.030. 0.035. 0.040
0, 0.006, 0.009, 0.012, 0.020, 0.025, 0.030, 0.035. 0.040
0, 0.006, 0.009, 0.012, o.o20, 0.025,0.030, 0.035. 0.040
0, 0.0015, 0.0030. 0.0090. 0.020. 0.035. 0.040
0, 0.0015, 0.0030, 0.0090, 0.020, 0.035, 0.040
0, 0.0015, 0.0030, 0.0090, 0.020, 0.035, 0.040
360
360
240
540
420
420
420
540
780
29"C. Tlae photoperiod was maintained at 12:12 h
light: dark.
Larvae were collected from the city cemetery
Camp Saint "El Roble." Larvae thriving in ceme-
tery vases were taken to the Medical Entomology
Laboratory at the University of Nuevo Le6n. Lar-
vae were identified and reared in 30 x 30-in. plastic
trays. Larvae were fed ground dog food. Adults
were fed IOVo sugar water. Females were also al-
lowed to take blood meals from mice. Field,col-
lected larvae were added every 2 months. The lar-
vae hatched from eggs obtained in the laboratory
corresponding to the F, progeny were utilized for
bioassays.
Bioassays were conducted as recommended by
the World Health Organization (1981); a total of 9
bioassays was conducted. Each of the bioassays in-
cluded 8 different B/i concentrations and 3 repli-
cates for individual concentrations. A control was
run concurTently in every bioassay series. Variation
in bioassay concentration was modulated by vari-
ation in larval susceptibility response; thereby, con-
centrations were adjusted to a mortality range of
1O-90Vo. To obtain each of the different Bti con-
centrations, Vectobac 12 AS was dissolved in de-
chlorinated water with the aid of a magnetic stirrer,
to provide a stock suspension of l7o. A series of
l%o stock dilutions was prepared (Table l) to pro-
vide the appropriate concentration ranges to deter-
mine mortality-concentration curves. Bioassays
were conducted on 2nd and 3rd larval instars ofAe.
aegypti. Larvae were not fed during the tests. Mor-
tality readings were taken after 24 h.
Mortality data were analyzed by probit analysis
by using the maximum likelihood method (Finney
1977). Data were corrected by using the Abbott
(1925) mortality correction formula when neces-
sary.
RESULTS AND DISCUSSION
Figure I and Table I indicate the concentration-
mortality relationship for Ae. aegypti after 24 h of
exposure to Vectobac 12 AS. According to the
maximum likelihood method, the median lethal
concentration (LCr,,) for 24 h exposure was 0.0104
ppm with a confidence interval of 0.0089-0.0120
ppm and the 95Vo lethal concentration was 0.1843
ppm with a confidence interval of O.1312-O.2856
ppm (P < 0.05).
The results showed a higher LCro value com-
pared to that observed by Vega (unpublished data),
who evaluated a Vectobac AS formulation against
larval Ae. aegypti collected in several localities
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Fig. l. Response to Vectobac 45o (24 h) in 2nd and 3rd larval instars of Aedes aegypti based on the maximum
likelihood method.
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from south and northeastern Mexico. In this latter
study, LCro values fluctuated between 0.0012 and
0.0026 ppm. As explained by Skovmand et al.
(1998), variation may be associated with such fac-
tors as age, stage, and strain of larvae used, as well
as amount and type of food provided to larvae.
These authors also demonstrated variation in the
LCro between laboratories in a quality control study
of different laboratories. They tested and compared
similar Bri products formulated by 6 different com-
panies from 4 different countries against the inter-
national standard powder IPS-82. They found sig-
nificant differences among companies related to the
potency of their products.
Becker et al. (1992) considered the possibility
that field application factors such as water temper-
ature and larval density may affect bacterial activity
on mosquito larvae. These investigators showed
that temperatures below 5oC produce lO-fold lower
toxicity compared to higher temperatures (>25"C)
against Aedes vexans (Meigen). Becker and his
group also demonstrated a reduction in bacterial ef-
fectiveness with an increase in larval density. Lee
and Seleena (unpublished data), in a separate study,
determined an LCro of O.OO27 mg/liter when utiliz-
ing Vectobac (an aqueous suspension of Bti l2OO
ITU/mg) against Ae. aegypti.
Amalraj et al. (2000) determined the efficacy of
aqueous suspension and granular formulations of
Brj (Vectobac). These laboratory tests showed that
aqueous suspensions were relatively more effective
against Culex quinquefasciatus Say than againstAe.
aegypti and Anopheles stephensi Liston. The LCro
value for Ae. aegypti was 0.060 mglliter.
The field dose was calculated at 4 times the LC.o
values resulting form the laboratory bioassays. This
concentration was adopted for use by the Ae. ae-
gypti Control Program. Vectobac 12 AS was poured
into 10,000-liter pipe-tank trucks. Trucks dispensed
water treated with Bti into 200-gal metal water
drums in the backyards of dwellings. Larval indices
for this specific container were reduced to zero dur-
ing the 2-wk treatment period. Dispensing of treat-
ed water was stopped when residents complained
of a fine dusty film appearing on the water surface
(Chif et al., unpublished data).
Finally, this study demonstrated the potential of
using .Bri fornulations against Ae. aegypti in Latin
America as an alternate larvicide when temephos
resistance is suspected or demonstrated. We agree
with local residents that appropriate formulations
should be made to prevent undesirable effects on
domestic water sources. Indeed, community accep-
tance is of paramount importance to the introduc-
tion of any new product.
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